Both in Pharmaceuticals
Azora Therapeutics vs BioVie
| Metric | AZR | BIVI |
|---|---|---|
| Price | $3.71 | $1.21 |
| Market cap | $9.7M | $10.5M |
| Today | −8.40% | −9.70% |
| 1 month | — | −13.6% |
| 6 months | — | −21.4% |
| Year to date | — | +4.3% |
| 1 year | — | −21.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $9.0M |
| Dividend yield | — | — |
| Volatility (60d) | — | 156.1% |
| Short % of float | — | 7.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).